Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001567619-22-017430

President and CEO sold 12,502 shares at $22.54 ($281,851)

  • President and CEO acquired 12,502 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Coulie Bernard President and CEO 2022-09-12 Option exercise +12,502 $2.08 $26,004 71,775 D: show line 1 in the form
Coulie Bernard President and CEO 2022-09-12 Sale −12,502 $22.54 $281,851 59,273 D: show line 2 in the form
Open-market sales · 12,502 sh · avg $22.54 · $281,851

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Coulie Bernard President and CEO 2022-09-12 Option exercise · Stock Option (right to buy) −12,502 297,380 D: show line 3 in the form
Loading xslF345X03/doc1.xml…